Tirzepatide Cost Per Month

Here are direct answers to the most common cost questions, including the brand-new Medicare change most sources haven’t caught up with yet.

• 1
  How much does tirzepatide cost per month? List price: ~$1,080–$1,086/month · Cash-pay vial programs: $299–$699 · With insurance + savings card: as low as $25 · New Medicare copay: $50/month starting this week

  The sticker price nobody actually pays is around $1,080 to $1,086 for a 28-day supply of either Zepbound or Mounjaro. What you actually pay depends on which path applies to you. Commercially insured patients with a manufacturer savings card can pay as little as $25 for a one- or three-month supply. Cash-pay patients using the manufacturer’s direct vial program typically land between $299 and $699 depending on dose. And starting this week, Medicare Part D enrollees have an entirely new option: a flat $50 monthly copay through a federal demonstration program that didn’t exist a few months ago. There is no single “the cost” — there’s a cost for your specific situation, and the rest of this guide is built to help you find yours.
• 2
  What is the Medicare GLP-1 Bridge program, and do I qualify? $50 flat monthly copay for weight-loss GLP-1s · Starts this week (July 1) · Covers Zepbound, Wegovy, and the pill Foundayo · Requires Part D enrollment and a documented BMI threshold

  This is genuinely new: Medicare has never before covered a medication specifically for weight loss, and that changes this week. If you’re enrolled in a Medicare Part D plan, your prescriber can document that you meet the clinical criteria — generally a BMI of 35 or higher on its own, or 30+ or 27+ with a qualifying condition like high blood pressure or high cholesterol — and you’ll pay a flat $50 a month regardless of dose. This runs as a separate federal program outside your normal Part D benefit, so the $50 doesn’t count toward your deductible or your annual out-of-pocket cap, but it also means your Extra Help low-income subsidy, if you have one, can’t be applied on top of it. If you’re already getting a GLP-1 through Part D for diabetes, sleep apnea, or heart disease risk, you stay on that existing coverage — this new program is specifically for the weight-loss use. Ask your prescriber to check your eligibility now; the program is expected to draw millions of applicants quickly.
• 3
  What’s TrumpRx, and is it actually cheaper? A new government-facilitated direct-to-consumer pricing platform · Tirzepatide vials priced around $346/month, down from list price · Not insurance — a cash-pay discount channel

  TrumpRx is a new platform created after the federal government negotiated “most-favored-nation” pricing agreements directly with Eli Lilly and Novo Nordisk, tying U.S. prices more closely to what other wealthy countries pay for the same drugs. Through this channel, tirzepatide vials are priced at roughly $346 a month on average — a real discount from the $1,000-plus list price, though still more than some manufacturer-direct vial programs. It is not insurance and doesn’t replace your existing coverage; it’s simply another cash-pay lane, similar in spirit to the manufacturer’s own direct program but running through a government-facilitated site instead. Because this is a very recently launched program, pricing and availability details are still settling — check the current listed price for your specific dose directly before assuming a number from an older article still applies.
• 4
  How much is Zepbound through the manufacturer’s direct vial program? $299/month for the 2.5mg starting dose · $399 for 5mg · $449–$699 for 7.5mg and higher, depending on refill timing

  Eli Lilly sells Zepbound directly to cash-pay patients through single-dose vials and a newer multi-dose pen, bypassing insurance and traditional pharmacy markups entirely. The starting 2.5mg dose runs $299 a month. The 5mg dose is $399. Higher doses — 7.5mg, 10mg, 12.5mg, and 15mg — are priced at $449 a month if you reorder within 45 days of your last shipment, but climb to $499–$699 if that refill window closes, so setting a calendar reminder around your delivery date genuinely saves real money. This program requires a valid prescription but does not require insurance, making it the most accessible FDA-approved brand-name option for anyone paying cash. Mounjaro, sold specifically for type 2 diabetes, does not currently have an equivalent direct-to-consumer vial program at similar pricing — if you’re prescribed Mounjaro and paying cash, expect to pay closer to full list price unless your prescriber is comfortable with the Zepbound formulation instead for weight management.
• 5
  Is compounded tirzepatide still legal, and is it actually safe? Legal only in narrow cases with documented medical necessity · No longer legal simply because it’s cheaper · The FDA has logged 320+ adverse event reports and is moving to close remaining loopholes

  This is where a lot of outdated advice online will genuinely mislead you. Compounded tirzepatide was widely and legally available during the 2022–2024 nationwide shortage, when pharmacies were permitted to make copies of the FDA-approved drug to fill the gap. That shortage officially ended, and the legal basis for mass compounding ended with it. As of now, a licensed compounding pharmacy can only legally prepare tirzepatide for you if there’s a documented, specific clinical reason the FDA-approved version won’t work — such as a genuine allergy to an inactive ingredient — not simply because it’s less expensive. The FDA has received more than 320 adverse event reports tied to compounded tirzepatide, including dosing errors from multi-dose vials that required hospitalization, and the agency is currently moving to permanently close the regulatory pathway that allowed bulk compounding in the first place. If a website or telehealth service offers compounded tirzepatide with no discussion of medical necessity — just a price and a form — that’s a signal to ask more questions before proceeding, not a deal to grab quickly.
• 6
  Why do I see prices as low as $99 or $149 a month online — is that real? Extremely unlikely to be genuine, FDA-quality-controlled tirzepatide · Prices that far below every legitimate channel usually signal counterfeit product, unregulated “research peptides,” or a bait-and-switch offer

  Every legitimate pathway to tirzepatide — brand-name direct vial programs, the new government TrumpRx platform, or properly licensed compounding under documented medical necessity — lands somewhere between $245 and $699 a month for real product. A price advertised at $99 or $149 sits well below every one of those channels, and that gap should raise a flag rather than feel like a lucky find. The FDA has specifically warned about counterfeit semaglutide and tirzepatide entering the country, and separately about products sold online labeled as “research peptides” that are explicitly not intended for human use, unregulated, and untested for sterility or dosing accuracy. If a price looks dramatically lower than everything listed in this guide, the most likely explanations are a low introductory rate that jumps sharply after the first order, an unregulated product with no quality oversight, or in rarer cases outright counterfeit medication. This is one area where the cheapest number is not the best number.
• 7
  Does insurance cover tirzepatide, and how do I find out? Coverage varies enormously by employer and plan · About 43% of large employers now cover GLP-1s for weight loss, up sharply from recent years · Type 2 diabetes coverage is far more consistent than weight-loss coverage

  Whether your insurance covers tirzepatide depends heavily on why it’s prescribed and who your employer or plan is. Coverage for Mounjaro, prescribed for type 2 diabetes, tends to be far more consistent across insurance plans than coverage for Zepbound prescribed purely for weight management. Among large employers offering health benefits, the share covering GLP-1 medications specifically for weight loss rose substantially in the past two years, though the majority of employer plans still don’t include this coverage. The only way to know your specific situation is to call your plan directly and ask two precise questions: is Zepbound (or Mounjaro, depending on your diagnosis) on the formulary, and is prior authorization required. If it’s covered, ask your prescriber about the manufacturer savings card, which can bring a covered prescription down to $25 for eligible patients. If it’s denied, you have the right to request a formulary exception, and your prescriber’s office can usually help file that paperwork.
• 8
  What’s the actual difference between Zepbound and Mounjaro if it’s the same drug? Same active ingredient, different FDA-approved uses · Zepbound: weight management · Mounjaro: type 2 diabetes · The distinction changes what insurance will and won’t cover

  Zepbound and Mounjaro both contain tirzepatide and are manufactured by the same company, but the FDA approved them for different specific uses — Zepbound for chronic weight management, Mounjaro for type 2 diabetes. That distinction matters enormously for what you’ll pay, because insurance plans, savings cards, and direct-to-consumer programs are often built around one brand and not the other. A doctor prescribing tirzepatide “off-label” — Mounjaro for weight loss without diabetes, for instance — happens clinically, but it can complicate which savings programs and coverage pathways actually apply. If cost is a major factor in your decision, it’s worth asking your prescriber directly which brand name gives you access to the better savings program for your specific situation, since the molecule itself is identical either way.
• 9
  Are there any other ways to lower the monthly cost? HSA/FSA funds apply to any legitimate path · Ask your prescriber about a lower maintenance dose once you’ve reached your goal · Some employer wellness programs now offer direct GLP-1 subsidies

  A few practical levers exist beyond the major programs already covered. Health Savings Account and Flexible Spending Account funds can be applied to tirzepatide with a valid prescription, whether you’re using brand-name vials, a covered prescription copay, or legitimately compounded medication — keep your receipts either way for documentation. Once you’ve reached a maintenance phase after significant weight loss, some prescribers will discuss whether a lower dose is clinically appropriate, which can reduce cost on programs where price scales with dose, though this should always be a clinical decision made with your prescriber rather than a cost-driven one made alone. A growing number of employers are adding direct GLP-1 subsidy programs to their wellness benefits separate from standard insurance coverage — it’s worth asking your HR department directly whether anything like this exists at your workplace, since these programs are often under-publicized even when available.

This table lays out the legitimate options from least to most expensive. Use it to find where your specific situation — insured, uninsured, on Medicare, or somewhere in between — actually lands.